Construction of Epstein-Barr virus-based expression vector containing mini-oriP - PubMed (original) (raw)
. 1999 Nov 2;264(3):938-43.
doi: 10.1006/bbrc.1999.1617.
Affiliations
- PMID: 10544034
- DOI: 10.1006/bbrc.1999.1617
Construction of Epstein-Barr virus-based expression vector containing mini-oriP
J Tanaka et al. Biochem Biophys Res Commun. 1999.
Abstract
Epstein-Barr virus (EBV)-based vectors are extrachromosomal vectors carrying a replicational origin, oriP (about 2200 bp) and a replication initiation factor (EBNA-1) which are sufficient for autonomous replication. Because one disadvantage of these vectors is their large sizes, we examined the effect of partial deletion of oriP on the effectiveness of the EBV-based vectors, using an enhanced green fluorescent protein (EGFP) as a reporter to monitor gene expression. Results indicated that 954 bp-deleted mini-oriP is useful in primate cells since the vector showed high efficiency of stable transfection, a high ratio of EGFP-positive cells, and high recovery of intact plasmid DNA from transfected cells.
Copyright 1999 Academic Press.
Similar articles
- An OriP/EBNA-1-based baculovirus vector with prolonged and enhanced transgene expression.
Shan L, Wang L, Yin J, Zhong P, Zhong J. Shan L, et al. J Gene Med. 2006 Dec;8(12):1400-6. doi: 10.1002/jgm.978. J Gene Med. 2006. PMID: 17051599 - Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells.
Mũcke S, Polack A, Pawlita M, Zehnpfennig D, Massoudi N, Bohlen H, Doerfler W, Bornkamm G, Diehl V, Wolf J. Mũcke S, et al. Gene Ther. 1997 Feb;4(2):82-92. doi: 10.1038/sj.gt.3300363. Gene Ther. 1997. PMID: 9081710 - Gene therapy progress and prospects: episomally maintained self-replicating systems.
Conese M, Auriche C, Ascenzioni F. Conese M, et al. Gene Ther. 2004 Dec;11(24):1735-41. doi: 10.1038/sj.gt.3302362. Gene Ther. 2004. PMID: 15385951 Review. - Improvement of nonviral gene therapy by Epstein-Barr virus (EBV)-based plasmid vectors.
Mazda O. Mazda O. Curr Gene Ther. 2002 Sep;2(3):379-92. doi: 10.2174/1566523023347814. Curr Gene Ther. 2002. PMID: 12189722 Review.
Cited by
- Detection of SARS-CoV-2 antibodies in serum and dried blood spot samples of vaccinated individuals using a sensitive homogeneous proximity extension assay.
Zhao H, Wang M, Muthelo P, Löf L, Sterky F, Gallini R, Kumar NV, Monsen T, Nilsson K, Åberg M, Kamali-Moghaddam M, Mei YF, Landegren U. Zhao H, et al. N Biotechnol. 2022 Dec 25;72:139-148. doi: 10.1016/j.nbt.2022.11.004. Epub 2022 Nov 21. N Biotechnol. 2022. PMID: 36423830 Free PMC article. - Lipid flippase dysfunction as a therapeutic target for endosomal anomalies in Alzheimer's disease.
Kaneshiro N, Komai M, Imaoka R, Ikeda A, Kamikubo Y, Saito T, Saido TC, Tomita T, Hashimoto T, Iwatsubo T, Sakurai T, Uehara T, Takasugi N. Kaneshiro N, et al. iScience. 2022 Feb 4;25(3):103869. doi: 10.1016/j.isci.2022.103869. eCollection 2022 Mar 18. iScience. 2022. PMID: 35243232 Free PMC article. - Epstein-Barr virus-based plasmid enables inheritable transgene expression in mouse cerebral cortex.
Satake T. Satake T. PLoS One. 2021 Sep 30;16(9):e0258026. doi: 10.1371/journal.pone.0258026. eCollection 2021. PLoS One. 2021. PMID: 34591902 Free PMC article. - Amplification of EBNA-1 through a single-plasmid vector-based gene amplification system in HEK293 cells as an efficient transient gene expression system.
Park SH, Park JH, Lee JH, Lee HM, Kang YJ, Lee EJ, Shin S, Lee GM, Kim YG. Park SH, et al. Appl Microbiol Biotechnol. 2021 Jan;105(1):67-76. doi: 10.1007/s00253-020-11001-3. Epub 2020 Nov 16. Appl Microbiol Biotechnol. 2021. PMID: 33191460 - Epstein-Barr virus-derived vector suitable for long-term expression in neurons.
Kiyosue K, Miwa Y. Kiyosue K, et al. Heliyon. 2020 Mar 11;6(3):e03504. doi: 10.1016/j.heliyon.2020.e03504. eCollection 2020 Mar. Heliyon. 2020. PMID: 32190754 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources